Details for Patent: 12,551,536
Which drugs does patent 12,551,536 protect, and when does it expire?
Patent 12,551,536 protects WEGOVY, WEGOVY FLEXTOUCH, and WEGOVY HD, and is included in one NDA.
This patent has thirty-two patent family members in eighteen countries.
Summary for Patent: 12,551,536
| Title: | Semaglutide in medical therapy |
| Abstract: | The present invention relates to semaglutide for use in weight management. |
| Inventor(s): | Maria Kabisch, Thomas Hansen |
| Assignee: | Novo Nordisk AS |
| Application Number: | US19/174,121 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 12,551,536 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 12,551,536
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-007 | May 5, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | METHOD OF WEIGHT REDUCTION VIA SUBCUTANEOUS ADMINISTRATION | ⤷ Start Trial | ||||
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-008 | May 5, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | METHOD OF WEIGHT REDUCTION VIA SUBCUTANEOUS ADMINISTRATION | ⤷ Start Trial | ||||
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-009 | May 5, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | METHOD OF WEIGHT REDUCTION VIA SUBCUTANEOUS ADMINISTRATION | ⤷ Start Trial | ||||
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-010 | May 5, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | METHOD OF WEIGHT REDUCTION VIA SUBCUTANEOUS ADMINISTRATION | ⤷ Start Trial | ||||
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-005 | Jun 4, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | METHOD OF WEIGHT REDUCTION VIA SUBCUTANEOUS ADMINISTRATION | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,551,536
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018348929 | ⤷ Start Trial | |||
| Australia | 2025203535 | ⤷ Start Trial | |||
| Brazil | 112020006246 | ⤷ Start Trial | |||
| Canada | 3078652 | ⤷ Start Trial | |||
| Chile | 2020000812 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
